Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

108.29 +4.17 (+4.01%)
Streaming Delayed Price Updated: 3:03 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 730,441
Open 107.46
Bid (Size) 108.26 (2)
Ask (Size) 108.32 (3)
Prev. Close 104.12
Today's Range 106.53 - 109.61
52wk Range 100.08 - 188.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer Treatment
BioNTech is testing out a next-generation form of Yervoy, hoping to reduce side effects. 
Via Investor's Business Daily
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
From BioNTech SE
Via GlobeNewswire

Performance

YTD
-27.15%
-27.15%
1 Month
-2.49%
-2.49%
3 Month
-15.38%
-15.38%
6 Month
-36.10%
-36.10%
1 Year
-32.94%
-32.94%

More News

Read More
7 Deeply Undervalued Growth Stocks to Buy in June
Via InvestorPlace
The Latest Analyst Ratings for BioNTech
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
What To Know About Redburn Partners's Upgrade of BioNTech
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today
Via Benzinga
Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases
Via Benzinga
Why Pfizer Stock Slipped by 2% Today
Via The Motley Fool
Expert Ratings for BioNTech
Via Benzinga
BioNTech Se (BNTX) Q1 2023 Earnings Call Transcript
Via The Motley Fool
A Look Into BioNTech Inc's Price Over Earnings
Via Benzinga
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases
Via Benzinga
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction
Via Benzinga
Why Novavax, Pfizer And BioNTech Shares Are Rising Today
Via Benzinga
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
Via The Motley Fool
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
Via Benzinga
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2023
Via Benzinga
Why Matinas BioPharma Stock Is Sinking Today
Via Benzinga
Woodstock For Capitalists
Via Benzinga
WHO Ends Global Emergency Status for COVID-19, Virgin Galactic Plans To Launch Space Tourism In Q2, Berkshire Hathaway Has No Intentions To Take Control Of Occidental Petroleum: Today's Top Stories
Via Benzinga
BioNTech Stock Jumps As Covid Vaccine Sales, Profits Beat Expectations
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.